AlzeCure Pharma (ALZCUR) — Cash Flow Reinvestment Rate
Latest as of March 2023:
0.00x
AlzeCure Pharma (ALZCUR) has a Cash Flow Reinvestment Rate of 0.00x as of March 2023, reinvesting Skr7.00K (capex Skr0.00 plus investments Skr7.00K) from operating cash flow of Skr28.09 Million. See ALZCUR equity financing ratio to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr7.00K
Capex + Investments
Operating Cash Flow
Skr28.09 Million
SEK
Capital Expenditures
Skr0.00
SEK
AlzeCure Pharma Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for AlzeCure Pharma across 1 annual periods. Also explore ALZCUR current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for AlzeCure Pharma (2023–2023)
Year-by-year capital reinvestment analysis for AlzeCure Pharma. For live market cap and broader valuation context, see ALZCUR company net worth.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.00x | Skr7.00K | Skr3.06 Million | Skr0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow